Journal of Medical Virology

Cover image for Journal of Medical Virology

December 1994

Volume 44, Issue 4

Pages fmi–fmi, 317–469

  1. Masthead

    1. Top of page
    2. Masthead
    3. Articles
    4. Symposium
    5. Articles
    1. Masthead (page fmi)

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440401

  2. Articles

    1. Top of page
    2. Masthead
    3. Articles
    4. Symposium
    5. Articles
    1. Polymerase chain reaction and sequencing for typing rhinovirus RNA (pages 323–329)

      Julie Mori and Jonathan P. Clewley

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440403

    2. Mixed cryoglobulinemia type II in chronic hepatitis B associated with HBe-minus HBV mutant: Cellular immune reactions and response to interferon treatment (pages 330–335)

      Hanns Löhr, Bernd Goergen, Wolfgang Weber, Werner Godderz, Karl-Hermann Meyer zum Büschenfelde and Guido Gerken

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440404

    3. Long-term follow-up of hepatitis B virus carrier infants (pages 336–339)

      Cho-Yu Chan, Shou-Dong Lee, May-Ing Yu, Yuan-Jen Wang, Yang-Te Tsai and Kwang-Juei Lo

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440405

    4. Molecular epidemiology of enterovirus outbreaks in Canada during 1991–1992: Identification of echovirus 30 and coxsackievirus B1 strains by amplicon sequencing (pages 340–347)

      Dr. Michael A. Drebot, Christopher Y. Nguan, Janice J. Campbell, Spencer H. S. Lee and Kevin R. Forward

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440406

    5. Development and preliminary evaluation of an enzyme immunosorbent assay for the detection of adenovirus type 8 (pages 348–352)

      S. R. Wood, I. R. Sharp, J. C. de Jong and M. W. Verweij-Uijterwaal

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440407

    6. Nucleotide sequence of the core region of hepatitis C virus in Pakistan and Bangladesh and the geographic characterisation of hepatitis C virus in South Asia (pages 362–368)

      Tomoyoshi Ohno, Masashi Mizokami, Christopher J. Tibbs, Kayhan T. Nouri-Aria, Rong-Rong Wu, Ken-Ichi Ohba, Etsuro Orito, Kaoru Suzuki, Naoto Mizoguchi, Tatsunori Nakano, Mobin Khan, Michitani Yano, Kendo Kiyosawa and Prof. Roger Williams

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440409

    7. Possible role for human papillomavirus 16 in squamous cell carcinoma of the finger (pages 369–378)

      Mary Sánchez-Lanier, Charla Triplett and Michael Campion

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440410

    8. Hepatitis C and arboviral antibodies in the island populations of mauritius and Rodrigues (pages 379–383)

      Dr. Tino F. Schwarz, Gerhard Dobler, Sabine Gilch and Gundula Jäger

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440411

    9. Hepatitis E seroprevalence in selected individuals in South Africa (pages 384–388)

      Prof. W. O. K. Grabow, M. O. Favorov, N. S. Khudyakova, M. B. Taylor and H. A. Fields

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440412

    10. Elimination of hepatitis delta virus infection after loss of hepatitis B surface antigen in patients with chronic delta hepatitis (pages 389–392)

      Manuel Battegay, Lisa H. Simpson, M.D. Jay H. Hoofnagle, Richard Sallie and Adrian M. di Bisceglie

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440413

    11. E2 and NS5: New antigens for detection of hepatitis C virus antibodies (pages 395–397)

      H. L. Zaaijer, D. S. Vallari, M. Cunningham, R. Lesniewski, H. W. Reesink, C. L. Der Van Poel and P. N. Lelie

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440415

    12. Monitoring of renal allograft recipients by quantisation of human cytomegalovirus genomes in peripheral blood leukocytes (pages 398–405)

      Dr. J. E. Kühn, T. Wendland, P. Schäfer, K. Möhring, U. Wieland, M. Elgas and H. J. Eggers

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440416

    13. Serum hepatitis C virus RNA level as a predictor of subsequent response to interferon-α therapy in Japanese patients with chronic hepatitis C (pages 410–414)

      Etsuro Onto, Masashi Mizokami, Tatsunori Nakano, Hisahiro Terashima, Osamu Nojiri, Kenji Sakakibara, Makoto Mizuno, Masataka Ogino, Makoto Nakamura, Yukoh Matsumoto, Ken-Ichi Miyata and Johnson Y. N. Lau

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440418

    14. Viral load as a determinant for transmission of human papillomavirus type 16 from mother to child (pages 415–421)

      Jeremy N. Kaye, John Cason, Farzin B. Pakarian, Richard J. Jewers, Barbara Kell, Jon Bible, Kankipati S. Raju and Jennifer M. Best

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440419

  3. Symposium

    1. Top of page
    2. Masthead
    3. Articles
    4. Symposium
    5. Articles
    1. Introduction for the symposium on hepatitis A vaccine (page 433)

      Arie J. Zuckerman

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440421

  4. Articles

    1. Top of page
    2. Masthead
    3. Articles
    4. Symposium
    5. Articles
    1. Single dose inactivated hepatitis A vaccine: Rationale and clinical assessment of the safety and immunogenicity (pages 435–441)

      Dr. P. van Damme, C. Matheï, S. Thoelen, A. Meheus, A. Safary and F. E. André

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440422

    2. Thermostability of an inactivated hepatitis A vaccine stored at 37°C for one week (page 442)

      Prof. Dr. G. Wiedermann, F. Ambrosch, F. E. André, A. Delem, E. D'hondt and A. Safary

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440423

    3. Inactivated hepatitis A vaccine: Reactogenicity, immunogenicity, and long-term antibody persistence (pages 446–451)

      Dr. P. van Damme, S. Thoelen, M. Cramm, K. de Groote, A. Safary and A. Meheus

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440425

    4. Clinical and immunological investigation of a new combined hepatitis A and hepatitis B vaccine (pages 452–456)

      Prof. Dr. F. Ambrosch, G. Wiedermann, F. E. André, A. Delem, H. Gregor, H. Hofmann, E. D'hondt, M. Kundi, J. Wynen and Ch. Kunz

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440426

    5. Interruption of an outbreak of hepatitis A in two villages by vaccination (pages 457–459)

      Dr. V. Príkazský, V. Oleár, A. Cernoch, A. Safary and F. E. André

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440427

    6. Advances in hepatitis A prevention in travellers (pages 460–462)

      Professor R. Steffen and D. Gyurech

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440428

    7. Cost-effectiveness analysis of vaccination against hepatitis A in travellers (pages 463–469)

      E. van Doorslaer, G. Tormans and P. van Damme

      Version of Record online: 7 DEC 2005 | DOI: 10.1002/jmv.1890440429

SEARCH

SEARCH BY CITATION